Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Lexeo Therapeutics Inc. shares valued at $40,496 were sold by Townsend Richard Nolan on Oct 10 ’24. At $8.10 per share, Townsend Richard Nolan sold 5,000 shares. The insider’s holdings dropped to 120,695 shares worth approximately $1.0 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Townsend Richard Nolan sold 5,000 shares, netting a total of over 53,274 in proceeds. Following the sale of shares at $10.65 each, the insider now holds 120,695 shares.
Before that, Richard Nolan Townsend had added 12,500 shares to its account. In a trade valued at $134,875, the Director bought Lexeo Therapeutics Inc. shares for $10.79 each.
As published in their initiating research note from Robert W. Baird on June 13, 2024, Lexeo Therapeutics Inc. [LXEO] has been an Outperform and the price target has been revised to $28. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of November 28, 2023, Stifel has initiated its “Buy” rating for LXEO. Earlier on November 28, 2023, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for LXEO stock.
Analyzing LXEO Stock Performance
During the last five days, there has been a drop of approximately -15.47%. Over the course of the year, Lexeo Therapeutics Inc. shares have dropped approximately -38.34%. A 50-day SMA is recorded $9.90, while a 200-day SMA reached $13.42. Nevertheless, trading volume fell to 1.15 million shares from 0.1 million shares the previous day.
Support And Resistance Levels for Lexeo Therapeutics Inc. (LXEO)
According to the 24-hour chart, there is a support level at 7.74, which, if violated, would cause prices to drop to 7.21. In the upper region, resistance lies at 9.16. The next price resistance is at 10.05. RSI (Relative Strength Index) is 40.16 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.09, which suggests the price will decrease in the coming days. Percent R is at 87.92%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
